Status:
RECRUITING
Effect of MTX Discontinuation on Shingrix Response in RA
Lead Sponsor:
Konkuk University Medical Center
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if methotrexate discontinuation affect on immunogeneity of shingrix in RA patients. The main questions it aims to answer are: Discontinuation of methotrexa...
Eligibility Criteria
Inclusion
- fulfill 2010 ACR/EULAR classification criteria for rheumatoid arthritis
- age over 19 years
- methotrexate user
- agree for vaccination with shingrix
Exclusion
- have other form of inflammatory arthritis or autoimmune-mediated disease
- malignancy, current infection, pregnancy
Key Trial Info
Start Date :
August 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06574594
Start Date
August 22 2024
End Date
December 31 2025
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, South Korea